List of drugs used to treat the medical condition called Bone Cancer. Click on the drug to find more information including the brand names, dose, side-effects, adverse events, when to take the drug and the price of the drug.
Generic and Trade Names of Drugs for Treatment of Bone Cancer
Aclarubicin or aclacinomycin A is used to treat acute non lymphocytic leukemia, a cancer of the blood and bone marrow.
Trade Names :
Burosumab-twza or KRN23 is a monoclonal antibody prescribed to treat a rare hereditary disorder called X-linked hypophosphatemia (low levels of phosphate in the blood) in adult and pediatric patients who are one year and above.
Dactinomycin is a cytotoxic chemotherapy, prescribed for Wilm's tumor, Ewing’s sarcoma and testicular cancer.
Trade Names :
Denosumab is a human monoclonal antibody, prescribed for osteoporosis, treatment induced bone loss, bone metastases, rheumatoid arthritis, multiple myeloma and giant cell tumor of bone.
Doxorubicin is a cytotoxic anthracycline antibiotic, prescribed for treating various types of cancer.
Trade Names :
More...
Elotuzumab is used to treat multiple myeloma, a type of cancer in the bone marrow in adult patients whose cancer has returned after successful treatment or in patients who showed treatment failure with one to three cancer treating medications.
Idelalisib is prescribed to treat patients with cancer of the blood or bone marrow such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, and follicular B-cell non-Hodgkin lymphoma (FL) whose cancer has returned after treating with some anti-cancer medicines.
Ivosidenib tablets for oral use are prescribed to treat acute myeloid leukemia (AML).
Ixazomib is used to treat multiple myeloma along with drugs lenalidomide and dexamethasone in adult patients who have already been treated with one therapy of cancer-treating medications.
Midostaurin is a kinase inhibitor prescribed as a combination therapy with cytarabine and daunorubicin for treating adult patients with acute myeloid leukemia who are detected as FLT3 mutation-positive by an FDA approved test.
Moxetumomab pasudotox-tdfk is prescribed to treat Hairy Cell Leukemia (HCL) in adult patients who had treatment failure with at least two treatments or whose cancer returned after chemotherapy.
Vindesine is used to treat several cancers such as leukemia, lymphomas, and some solid tumors such as breast cancer and lung cancer either as a single agent or in combination with other cancer-treating drugs.
This site complies with the HONcode standard for trustworthy health information: verify here.
